Alec Vahanian

10.5k total citations · 1 hit paper
17 papers, 1.3k citations indexed

About

Alec Vahanian is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Epidemiology. According to data from OpenAlex, Alec Vahanian has authored 17 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 6 papers in Surgery and 6 papers in Epidemiology. Recurrent topics in Alec Vahanian's work include Cardiac Valve Diseases and Treatments (8 papers), Infective Endocarditis Diagnosis and Management (5 papers) and Acute Myocardial Infarction Research (5 papers). Alec Vahanian is often cited by papers focused on Cardiac Valve Diseases and Treatments (8 papers), Infective Endocarditis Diagnosis and Management (5 papers) and Acute Myocardial Infarction Research (5 papers). Alec Vahanian collaborates with scholars based in France, United States and Germany. Alec Vahanian's co-authors include Amadeo Betriu, Eric J. Topol, Dean J. Kereiakes, J. Jeffrey Carr, Eric A. Cohen, Pim J. de Feyter, Douglas Spriggs, A. Michael Lincoff, Frederick Feit and Ian J. Sarembock and has published in prestigious journals such as JAMA, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Alec Vahanian

15 papers receiving 1.3k citations

Hit Papers

Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockad... 2003 2026 2010 2018 2003 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alec Vahanian France 8 1.2k 621 475 152 150 17 1.3k
Axel de Labriolle United States 19 1.3k 1.1× 759 1.2× 338 0.7× 305 2.0× 100 0.7× 54 1.6k
HD White New Zealand 12 1.1k 0.9× 394 0.6× 175 0.4× 344 2.3× 65 0.4× 51 1.2k
Michele Voeltz United States 10 1.2k 1.0× 650 1.0× 466 1.0× 105 0.7× 43 0.3× 20 1.4k
Zenon Huczek Poland 20 1.3k 1.1× 438 0.7× 300 0.6× 159 1.0× 351 2.3× 116 1.5k
Alexander G. G. Turpie Canada 10 1.3k 1.1× 404 0.7× 717 1.5× 237 1.6× 167 1.1× 17 1.5k
Atul Aggarwal United States 18 677 0.6× 456 0.7× 163 0.3× 181 1.2× 80 0.5× 34 925
Carolyn H. McCabe United States 16 1.1k 0.9× 420 0.7× 152 0.3× 396 2.6× 151 1.0× 21 1.3k
Petr Widimský Czechia 17 1.2k 1.0× 560 0.9× 231 0.5× 220 1.4× 34 0.2× 36 1.3k
M. L. Simoons Netherlands 17 1.6k 1.4× 823 1.3× 197 0.4× 509 3.3× 115 0.8× 45 2.0k
Francesco Costa Italy 21 2.1k 1.8× 1.2k 1.9× 432 0.9× 187 1.2× 78 0.5× 91 2.4k

Countries citing papers authored by Alec Vahanian

Since Specialization
Citations

This map shows the geographic impact of Alec Vahanian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alec Vahanian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alec Vahanian more than expected).

Fields of papers citing papers by Alec Vahanian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alec Vahanian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alec Vahanian. The network helps show where Alec Vahanian may publish in the future.

Co-authorship network of co-authors of Alec Vahanian

This figure shows the co-authorship network connecting the top 25 collaborators of Alec Vahanian. A scholar is included among the top collaborators of Alec Vahanian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alec Vahanian. Alec Vahanian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Mesnier, Jules, Dimitri Arangalage, Grégory Ducrocq, et al.. (2025). Survival outcomes in isolated severe tricuspid regurgitation according to therapeutic modalities: a systematic review and meta-analysis. Open Heart. 12(1). e002986–e002986.
2.
Klautz, Robert J.M., Michele De Bonis, Frank Langer, et al.. (2019). The optimal treatment strategy for secondary mitral regurgitation: a subject of ongoing debate. European Journal of Cardio-Thoracic Surgery. 56(4). 631–642. 6 indexed citations
3.
Verdonk, Constance, Claire Cimadevilla, Laurent Lepage, et al.. (2018). Systematic transoesophageal echocardiography after mitral valve replacement: Rates and determinants of paravalvular regurgitation. Archives of cardiovascular diseases. 111(8-9). 528–533. 5 indexed citations
4.
Arsalan, Mani, Eustachio Agricola, Ottavio Alfieri, et al.. (2016). Effect of Transcatheter Mitral Annuloplasty With the Cardioband Device on 3-Dimensional Geometry of the Mitral Annulus. The American Journal of Cardiology. 118(5). 744–749. 10 indexed citations
5.
Obadia, Jean‐François, Xavier Armoiry, Bernard Iung, et al.. (2015). The MITRA-FR study: design and rationale of a randomised study of percutaneous mitral valve repair compared with optimal medical management alone for severe secondary mitral regurgitation. EuroIntervention. 10(11). 1354–1360. 34 indexed citations
6.
Maisano, Francesco, Maurizio Taramasso, Georg Nickenig, et al.. (2015). Cardioband, a transcatheter surgical-like direct mitral valve annuloplasty system: early results of the feasibility trial. European Heart Journal. 37(10). 817–825. 114 indexed citations
7.
Werf, Frans Van de, Diego Ardissino, Amadeo Betriu, et al.. (2005). MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS PRESENTING WITH ST-SEGMENT ELEVATION. Rational Pharmacotherapy in Cardiology. 1(2). 62–95. 237 indexed citations
8.
Tanguay, Jean‐François, Mitchell W. Krucoff, Raymond J. Gibbons, et al.. (2003). Efficacy of a novel P-selectin antagonist, rPSGL-Ig for reperfusion therapy in acute myocardial infarction: The RAPSODY trial. Journal of the American College of Cardiology. 41(6). 404–405. 18 indexed citations
9.
Lincoff, A. Michael, John A. Bittl, Robert A. Harrington, et al.. (2003). Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention. JAMA. 289(7). 853–853. 836 indexed citations breakdown →
10.
Werf, Frans Van de, Diego Ardissino, Amadeo Betriu, et al.. (2003). Trattamento dell'infarto miocardico acuto in pazienti con sopraslivellamento del tratto ST all'esordio della sintomatologia. Task Force sulla Gestione dell'Infarto Miocardico Acuto della European Society of Cardiology. 4(12). 981–1016.
11.
Lefèvre, Guillaume, et al.. (1998). Comparaisons analytique et diagnostique de deux dosages de l'isoenzyme MB de la créatine kinase et de deux dosages de la troponine I par méthode immunoenzymologique. Immuno-analyse & Biologie Spécialisée. 13(3). 167–173. 2 indexed citations
13.
Vahanian, Alec. (1996). Thrombolytic therapy in Europe: current status. European Heart Journal. 17(suppl E). 21–27. 4 indexed citations
14.
Tharaux, Pierre‐Louis, et al.. (1994). Plasma Atrial and Brain Natriuretic Peptides in Mitral Stenosis Treated by Valvulotomy. Clinical Science. 87(6). 671–677. 21 indexed citations
15.
16.
17.
Acar, J & Alec Vahanian. (1987). La valvuloplastie mitrale percutanée: nouvelle thérapeutique du rétrécissement mitral.. Archives Des Maladies Du Coeur Et Des Vaisseaux. 80(7). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026